Microscopic kinetics and energetics distinguish GABA(A) receptor agonists from antagonists

Biophysical Journal
M V JonesG L Westbrook

Abstract

Although agonists and competitive antagonists presumably occupy overlapping binding sites on ligand-gated channels, these interactions cannot be identical because agonists cause channel opening whereas antagonists do not. One explanation is that only agonist binding performs enough work on the receptor to cause the conformational changes that lead to gating. This idea is supported by agonist binding rates at GABA(A) and nicotinic acetylcholine receptors that are slower than expected for a diffusion-limited process, suggesting that agonist binding involves an energy-requiring event. This hypothesis predicts that competitive antagonist binding should require less activation energy than agonist binding. To test this idea, we developed a novel deconvolution-based method to compare binding and unbinding kinetics of GABA(A) receptor agonists and antagonists in outside-out patches from rat hippocampal neurons. Agonist and antagonist unbinding rates were steeply correlated with affinity. Unlike the agonists, three of the four antagonists tested had binding rates that were fast, independent of affinity, and could be accounted for by diffusion- and dehydration-limited processes. In contrast, agonist binding involved additional energy-req...Continue Reading

References

Sep 15, 1979·Biochemical Pharmacology·P R Andrews, G A Johnston
Sep 1, 1992·Neuron·R J VandenbergP R Schofield
Apr 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·J Bormann, D E Clapham
Mar 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·J P ChambonC G Wermuth
Jan 1, 1982·Annual Review of Pharmacology and Toxicology·R W Olsen
Jun 1, 1984·Proceedings of the National Academy of Sciences of the United States of America·M B Jackson
Oct 1, 1995·Trends in Pharmacological Sciences·M J Lew, J A Angus
Jul 17, 1998·Science·P JonasJ Sandkühler
Dec 18, 1998·Neuron·J P Changeux, S J Edelstein
Apr 9, 1999·Nature Neuroscience·Y Chang, D S Weiss

❮ Previous
Next ❯

Citations

Mar 22, 2002·British Journal of Pharmacology·Michael F Jarvis, Edward C Burgard
Sep 6, 2007·Proceedings of the National Academy of Sciences of the United States of America·János SzabadicsIvan Soltesz
Apr 22, 2011·The Journal of Biological Chemistry·Zeynep Kasap VarleyPaola Zacchi
Jun 27, 2012·The Journal of General Physiology·Snehal Jadey, Anthony Auerbach
Mar 1, 2013·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Agnieszka I WlodarczykMatthew C Walker
Jul 28, 2010·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Theofanis KarayannisMarco Capogna
Nov 26, 2010·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Craig J Dietrich, Martin Morad
Sep 18, 2002·Proceedings of the National Academy of Sciences of the United States of America·Marlene BartosPeter Jonas
Dec 24, 2014·Proceedings of the National Academy of Sciences of the United States of America·Carmen E FloresDominique Muller
May 26, 2009·Molecular and Cellular Neurosciences·Zhanyan Fu, Stefano Vicini
Feb 4, 2006·The Journal of Physiology·Gareth M C Lema, Anthony Auerbach
Sep 25, 2003·British Journal of Pharmacology·Valeria CostaPaolo Carloni
Sep 10, 2014·Frontiers in Cellular Neuroscience·Thierry R NieusEgidio D'Angelo
Jun 26, 2003·Science's STKE : Signal Transduction Knowledge Environment·Anthony Auerbach
Sep 22, 2006·Brain Research·Lawrence N EisenmanSteven Mennerick
Apr 4, 2006·Nature Neuroscience·Kenichi N HartmanVenkatesh N Murthy
Sep 24, 2004·The European Journal of Neuroscience·Andrea BarberisEnrico Cherubini
May 25, 2010·Journal of Neurochemistry·Molly N Brown, Gregory C Mathews
Aug 3, 2011·Journal of Neurochemistry·Phu N TranDavid A Wagner
Aug 30, 2012·The Journal of Physiology·Mirosława MańkoMarco Capogna
Jan 7, 2005·Molecular Pharmacology·Andrea BarberisJerzy W Mozrzymas
Feb 26, 2003·The Journal of Biological Chemistry·Enrica Maria PetriniEnrico Cherubini
Aug 27, 2003·The Journal of Physiology·Lawrence N EisenmanSteven Mennerick
Mar 29, 2019·Scientific Reports·Antoine D MadarMathew V Jones
Jan 13, 2019·The Journal of General Physiology·Tapan K NayakAnthony Auerbach
May 16, 2017·Advanced Materials·Ilke UguzGeorge G Malliaras
Nov 28, 2006·Neuropharmacology·Henrik Tang VestergaardUffe Kristiansen

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Acta Crystallographica. Section C, Crystal Structure Communications
K FrydenvangB Jensen
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
David A WagnerM V Jones
© 2021 Meta ULC. All rights reserved